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Abstract— Rotenone is a pesticide that is widely used to kill 
insects and nuisance fish in lakes. Its used as Parkinson’s Disease 
(PD) model inducer. The mechanism of toxicity of rotenone is 
primarily mediated by its potential as mitochondrial complex I 
inhibition. Centella asiatica (CA) is known as neurotonic, but how 
its potential protection in Parkinsonism is still unclear. In this 
study, we examined the effect of CA to Brain-derived 
Neurotrophic Factor (BDNF) as a neuroprotectant and apoptosis  
as hallmark of PD in rotenone-induced zebrafish (Danio rerio). 
Besides, we also measured the zebrafish motility and dopamine 
(DA) level in the brain. We used adult zebrafish (8 months). Its 
exposed to 5 g/L rotenone and co-incubated with methanolic 
extract of CA by several concentrations which are 2.5, 5 and 10 
µg/mL for 28 days. Motility observed for 5 minutes at 0, 7, 14, 21 
and 28 days. Measurement DA by ELISA, BDNF and apoptosis 
by immunohistochemistry. The results showed that CA 
significantly (p<0.05) increased motility and dopamine level in all 
concentration of extract.  Interestingly, BDNF expression in 5 
and 10 µg/mL groups had no significantly difference to the 
control group. Concentration 10 µg/mL could protect 
dopaminergic neuron from rotenone toxicity due to significantly 
(p<0.05) decreased compare to rotenone group. Together, these 
data suggest that methanolic extract of CA could protect 
Parkinsonian syndrome conserved dopaminergic neuron through 
increasing BDNF as neurotrophic factor.  
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I.  INTRODUCTION  
Parkinson's disease (PD) the most common movement 
disorder and the second most common neurodegenerative 
disease after Alzheimer's disease, is characterized primarily by 
the loss of dopaminergic neurons in the substantia nigra pars 
compacta leading to a dopamine deficit in the striatum1. The 
consequent dysregulation of basal ganglia circuitries accounts 
for the most prominent motor symptoms, including 
bradykinesia, hypokinesia, rigidity, resting tremor and postural 
instability. In addition to the typical motor symptoms, various 
non-motor features may develop, such as autonomic 
dysfunction, sleep disturbances, depression and cognitive imp 
airment, indicating a more  widespread degenerative process. 
A pathological hallmark of sporadic PD is the presence of 
proteinaceous deposits within neuronal perykarya (Lewy 
bodies) and processes (Lewy neurites), mainly composed of α-
synuclein, ubiquitin, neurofilaments and molecular 
chaperones2. 
Rotenone is the most potent member of  the rotenoids, a 
family of isoflavonoids extracted from Leguminosae plants 
and used as an organic pesticide. Being highly lipophilic, it 
freely crosses the cell membrane, blood–brain barrier and 
causes neurotoxicity by the inhibition of complex I of the 
mitochondrial electron transport chain and destroy specific 
dopaminergic neuron, formation of ubiquitin and α-synuclein-
positive nigral inclusions and motor deficit3,4,5,6. Many studies 
have employed rotenone to generate an experimental animal 
model of  Parkinson’s disease (PD) that mimics and elicits 
PD-like symptoms, such as motor and cognitive decline7.   
Zebrafish is a promising animal for modelling PD as their 
dopaminergic nervous system has been well characterized and 
they have more similar PD gene homology than C. elegans 
and Drosophila8. Zebrafish have the potential to address some 
of the more traditional animal model limitation; for example, 
they have shorter generation time and an enormous amount of 
offspring, although more studies are require before conclusion 
can be drawn regarding the viability of this animal to model 
PD. No studies, to our knowledge, have assessed non-motor 
symptoms using rotenone zebrafish model of PD. Bretaud and 
colegeus exposed rotenone 2µg/L for 4 weeks to zebrafish 
found there were no alteration in locomotion, respiration or 
skin pigmentation, but 10 µg/L was shown to be lethal for 
adult. So, in this research we used rotenone 5 µg/L for 4 
weeks to made parkinsonian  symptoms9.  
Centella asiatica (CA) is a small herbaceous annual plant 
of the family Apiaceae, and its native to Indonesia, India, 
Srilanka, northern Australia, Malaysia and other part of Asia. 
It is used as a medicinal herb in Ayurvedic medicine, 
traditional African Medicine, and traditional Chinese 
medicine10. The primary active constituents of CA are 
saponins (also called triterpenoids), which include 
asiaticosides, in which a trisaccharide moiety is linked to the 
aglycone asiatic acid, madecassoside and madasiatic acid. 
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Other components isolated from CA, such as brahmoside and 
brahminoside, may be responsible for CNS and utero relaxant 
actions, but are yet to be confirmed by clinical studies11. Our 
Previous study showed that methanolic extract of CA could 
increase, BDNF, BCl-2, decreased MAPK-p38, iNOS and 
apoptosis of neuronal cells of Rattus noevegicus strain Wistar 
exposed to lipopolysaccharide (LPS)12 (Khotimah, et al., 
2010) and asiaticoside decreased apoptosis in LPS-induced 
zebrafish embryo13.  Xu and collegeus proved that 
maecasoside from CA protected rat induced by MPTP by 
improved locomotor dysfunction, increased dopamine (DA) in 
striatum, decreased MDA (malonedealdehyde), while 
increased GSH, BCl2/Bax ration, and BDNF expression14. In 
this research we investigated standardized methanolic extract 
of CA to rotenone-induced zebrafish especially on the 
expression of BDNF and BDNF, besides we also measured the 
DA level, locomotor activity and asiaticoside level as 





Adult male and female zebrafish were obtained from 
commercial suppliers from Tulungangung, East Java, 
Indonesia. Zebrafish identified at Hydrology Laboratory of 
Fishery Faculty Brawijaya University. Before treatment 
zebrafish adapted in semi-static 60 L tank and rear as standard 
procedure15. Fish fed three times daily (Tetra Bit and Color 
Tropical Flakes, Tetra Sales, Blacksburg, Germany), and kept 
on a 14:10 light–dark cycle. Water temperature was 
maintained between 28±1 ºC. All procedures were approved 
by the Ethical Committee of Medical Faculty Brawijaya 
University 
B. Collection, Extraction and Asiaticoside  measurement 
from  Centella asiatica 
Centella asiatica was gained from Materia Medica, 
Batu, Malang, Indonesia. The aerial part (leaves and branch 
above ground) was washed and dried. Dried powder of CA 
(100 g) was diluted in 900 ml of  96% methanol (maceration) 
and evaporate in 67C. The asiaticoside level in the extract 
was then measured as one of a biomarker of CA with ultra 
high-performance liquid chromatography (UHPLC) 
(Thermoscientific, Accela 1250). Mobile phase 0,1% formic 
acid in water and 0,1% formic acid in acetonytril, flow rate 
250 µL/min, hypersil gold column (50x2.1x1.9µM).  
C. Rotenone and CA Treatment  
Rotenone (Sigma 8875) concentration based on 
explorative experiment. Bretaud and colleagues9 used 2 g/L 
rotenone and had no significantly effect on adult zebrafish. 
We used 2, 5 and 10  g/L rotenone for 28 days exposure. 
Finally, we found an appropriate concentration was 5 g/L. 
Rotenone concentration 2 g/L  had no effect on zebrafish 
motility and rotenone 10 g/L caused fish died after 48 hours 
(data not shown). CA extract was diluted in aquadest 1 mg/mL 
as stock, and final concentration were 2.5, 5 and 10 µg/mL 
after exploration experiment. The medium was added with 
anti-chlorine, rotenone and CA extract, homogenized before 
fish introduction. Five fish placed in 25x16x12 cm tank for 
each group, fed 3 times daily and change the medium every 48 
hours. 
D. Motility Observation 
The locomotor activity of adult zebrafish was assessed in 
a 2L tank (LxWxH: 25x16.5x12.5 cm) filled with 2 L system 
water. As the normal behaviour of fish is to swim back and 
forth along the length of the tank, simple observation was used 
to determine the locomotor activity of adult zebrafish. Three 
vertical lines were drawn on the tank at equal distances, 
dividing the tank into four zones (the length of each zone was 
6.25 cm). Locomotor activity was measured for 5 min by 
counting the number of lines that adult zebrafish crossed. 
Therefore, the total distance that the adult zebrafish travelled 
was in direct proportion to the total number of lines that the 
fish crossed. The locomotor activity was calculated by the 
total number of lines that the zebrafish crossed, divided by 
time, and were expressed in a number of crossed lines/5 min9. 
E. Dopamine Measurement by ELISA 
Zebrafish were euthanized using the standard NIH 
recommended methods by submersion in ice water (5 parts 
ice/1 part water, 0-4º C) for 30 seconds following cessation of 
opercular (i.e., gill) movement. The head part then extracted to 
get the protein for dopamine ELISA (Fast Track procedure 
base on LDN). The samples of each group gained from 3 
heads of zebrafish. 
F. Expression of BDNF and Apoptosis by 
Immunohistochemistry 
After 28 days zebrafish were sacrificed to obtain the brain 
by decapitation of head in ice water. The head was infiltrated 
by buffer formalin 10%  and immediately immersed in buffer 
formalin for 24 h preparing for paraffin block. The head was 
sliced (without decalcification) 0.4 µM thick and prepare for 
immunohistochemistry.  The slide was de-paraffinized and 
stained based on vendor manual procedure. Primary antibody 
we used  BDNF (SantaCruz) and TUNNEL for apoposis 
(ApopTag@Peroxidase). The expression BDNF and apoptosis 
(brown) observed in the midbrain area of zebrafish brain. Each 
slide observed in 1000 times magnification for 20 field of 
view in different area and average the data and each group 
contained 3 zebrafish head (3 slide)16,17. 
G.  Statistical Analysis 
All the grouped data were statistically evaluated by 
SPSS/10 software. Hypothesis testing methods included one 
way analysis of variance (ANOVA) followed by least 
significant difference (LSD) test. P values of less than 0.05 
were considered to indicate statistical significance. All these 




A. Asiaticoside measurement 
Asiaticoside chosen as biomarker and standard active 
compound in this research. Fig 1 showed the result of UHPLC 
running and based on standard curve, we found the 
asiaticoside concentration was 2.94 ppm. 
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Figure 1. Ultra High Performance Liquid Chromatography (UHPLC). Sample 
and standard asiaticoide injection showed that retention time is 
around 2 minutes (left panel), and standart curve for asiaticoside.  
B. Motility Assesment 
We were figuring out the effect of methanolic extract CA 
only to the zebrafish motility (Fig.2) to know whether it could 
affect fish in the same concentration. And we found that CA 
did not significantly changed the motility. But rotenone caused 
decreasing locomotor activity starting at day 14th (Fig. 3).  
 
Figure 2. The mean of motility zebrafish measured on day 0, 7, 14, 21 and 
28 for each group : Control ©, exposed to CA extract 2.5, 5 and 10 µg/mL. It 
showed that no significant differences among groups. 
 
 
Figure 3. The mean of motility zebrafish measured on day 0, 7, 14, 21 
and 28 for each group. Control (C), Rotenone (R), Rotenone and CA 2.5 µg/ml 
(RCA2.5), Rotenone and CA 5 µg/ml (RCA5), and Rotenone and CA 10 µg/ml 
(RCA10). The graph showed that the motility tend to decrease with time, but in 
the control group there are no significant differences amongst time observation. 
Rotenone decreased motility significantly starting from day 14th  and 
continuing decreased at 21st and 28th days. CA administration gradually 
increased the zebrafish motility on dose dependent manner. 
C. Dopamine Level 
Rotenone 5µg/L for 28 days decreased dopamine level in 
zebrafish brain and methanolic CA extract gradually increased 
DA by increasing concentration of CA (fig. 4).  
 
Figure 4. Dopamine level showed significantly decreased by sub-chronic 
exposure (28 days) of rotenone, and CA gradually increased the dopamine 
concentration in zebrafish brain by increasing concentration of CA. 
Interestingly, administration of CA 10 µg/ml had no significant difference 
with the control group. Different notation shows significantly different from 
the DA level (P<0.05). 
D. BDNF Expression and Apoptosisof Dopaminergic Neuron 
 
Figure 5. Histological feature of Zebrafish brain by Hematoxillen-Eosine 
staining of zebrafish brain (A) and Brain mapping of zebrafish18 (B). We 
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Figure 6. BDNF expression in Dopaminergic Neuron. Rotenone 5 µg/mL 
significantly decreased the BDNF expression, and CA extract gradually 
increased BDNF in dose-dependent manner.  
 
Figure 7. Apoptosis (DNA fragmentation) of Dopaminergic neuron by 
TUNNEL assay. Rotenone significantly increased apoptosis in dopaminergic 
neuron, and CA extract 10 µg/mL signifcantly decreased apoptosis and had no 
significant different to control. 
 
IV. DISCUSSION 
A.  Rotenone-induced Parkinsonian Syndrome  
Rotenone is a pesticide derived from the plant roots of 
leguminosae family. It is highly lipophilic and therefore easily 
crosses all biological membranesincluding the blood–brain 
barrier; hence, it is independent of transporters for entry into 
cells19. Rotenone produces the pathologic hallmark features of 
PD because of its neurotoxic effects. Thus, rotenone exposure 
in rats provides a valuable model for studying mechanisms of 
oxidative stress induced dopaminergic damage in PD20. Its 
lipophilic nature allows systemic administration rendering it 
less technically demanding than models such as 6-OHDA 
model, which requires stereotactic injections into the brain. 
Rotenone inhibits complex I of the mitochondrial electron 
transport chain leading to reduced ATP production and 
electron leakage that can form reactive oxygen species such as 
superoxide, subsequently causing reduced glutathione levels 
and oxidative stress21.  
Fig. 3 showed the motility dereased due to rotenone-
induced, while CA extract only showed stabile motility (fig.2). 
The decreased motility significantly started from 14 days and 
continuing decreased until the end of experiment (28 days). 
This decrease may due to the decreasing of dopamine (DA) 
level in the brain (fig. 4). Since its discovery as a prominent 
chemical neurotransmitter in the vertebrate nervous system, 
dopamine (DA) is recognized to have many important 
physiological functions including the control of movement, 
cognition, affect, as well as neuroendocrine secretion22. In 
adult zebrafish DA neurons are conspicuously absent from the 
ventral midbrain, the ventral forebrain DA neurons ascending 
to the striatum (where ventral midbrain DA neurons in 
mammals project) are likely the functional counterpart of the 
mammalian midbrain DA neurons23.  
Increasing dopaminergic neurotransmission lead to 
increases  locomotor activity and decreasing in dopaminergic 
neurotransmission lead to decreased locomotor activity24. The 
decreasing dopamine level due to both synthesis by tyrosine 
hydroxylase (TH) and degradation of dopamine by free 
radicals. In this research showed that TH was decreased in 
rotenone group and increased in CA extract administration 
groups (data not shown). The decreasing locomotor activity of 
zebrafish seems due to mitochondrial dysfunction as power 
house of the cells that caused depleting ATP production, 
disruption of mitochondrial permeability, increasing Ca2+ and 
overproduction of reactive oxygen species. These conditions 
can lead to autooxidation of dopamine or its enzyme (TH), 
therefore decreasing dopamine as neurotransmitter for 
motility. On the other hand, stress oxidative by mitochondrial 
dysfunction lead to releasing caspase familiy protein and 
apoptosis of dopaminergic neuron in substantia nigra 
(neuronal loss). There are association between dopaminergic 
damage and peripheral motor nerve degeneration in an animal 
model of dopaminergic toxicity. Peripheral motor nerve 
dysfunction in rats following a chronic exposure to rotenone 
may serve not only as a relevant experimental model of motor 
neuropathy but also as a peripheral marker of dopaminergic 
neuronal damage to the central nervous system25. 
B. CA Extract Protect Zebrafish-induced Rotenone through 
the Increasing BDNF  
Secondary metabolites from plant have important role for 
ecological, agriculture, industrial and medicinal aspects. It has 
been estimated that over 40% of medicines have their origins 
in these active natural products26. CA is reported to contain 
numerous phtoconstituents (terpenes, glycosides, saponins, 
flavonoids, alkaloids,etc.) as secondary metabolites27. The 
chemical composition of CA has a very important role in 
medicinal and nutraceutical applications and it is believed due 
to its biologically active components of triterpenes saponins28. 
Major bioactive compounds of this plant contain highly 
variable triterpenoid saponins, including asiaticoside, asiatic 
acid, madecassoside, oxyasiaticoside, centelloside, 
brahmoside, brahminoside, thankunoside, isothankunoside and 
related sapogenins29. Asiatic acid, madecassic acid and 
madecassoside, therefore its used as biomarker for quality 
assessment of CA30. Methanolic CA extract in this research 
contain 2.94 ppm of asiaticoside (fig. 1). Many research 
showed the neuroprotective effect of CA through the 
antioxidant and anti inflammatory property of CA31. Based on 
standard curve formula (Fig. 1,B) we found that biomarker  
concentration of asiaticoside was 2.9 ppm.  
Our Previous study32 showed that methanolic extract of 
CA increased BDNF expression, decreasing of nuclear factor 
kappa beta (NFkB), iNOS and apoptosis in LPS-induced 
neuronal cell of rat. BDNF is abundant in the brain and is 
important for neuronal growth, survival and differentiation of 
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neuronal cells in the central nervous system. In the brain, the 
synthesis of BDNF, as investigated in the hippocampus and 
cortex, is affected by neuronal activity and has a unique role in 
synaptic plasticity33. It was the first neurotrophin described to 
promote the survival and dopamine uptake of embryonic 
midbrain dopaminergic neurons in vitro, thus it was 
considered early on as a crucial protein for Parkinson’sdisease 
(PD). BDNF enhances survival of dopaminergic neurons in 
the substantia nigra, whereas in patients with Parkinson’s 
disease (PD), the expression of BDNF mRNA is decreased34.  
In this research, methanolic extract of CA increased 
locomotor activity by increasing DA level (Fig. 3 and fig. 4), 
while CA extract alone did not made any significant changing 
(Fig. 2). Its seems that CA could protect from rotenone 
toxicity through the protection to mitochondria. CA protects 
rotenone-induced SH-SY5Y cells through the stability of 
mitochondrial membrane potential (MMP) and inhibiting  
voltage-dependent anion channel (VDAC) enzyme35,36. 
Madecassoside increased inhibition of Monoamine oxidase 
(MAO)37.  MAO A and B are key isoenzymes that degrade 
biogenic and dietary amines. Both form can oxidize DA38. 
In the other hand antioxidant property of CA also have 
important roles to protect the dopaminergic neuron. Aqueous 
extract of CA on intracerebrovascular streptozocin-induced 
memory associated with the sporadic type of AD and 
pentylenetetrazole(PTZ)- induced memory loss in rats showed 
the increasing neuroprotection through suppression of MDA 
(malondealdehiyde) and increasing antioxidant enzyme 
catalase, superoxide dismutase (SOD) and glutathione39,40 
(kumar ; Gupta). Inhibitory activity of the aqueous extract of 
CA that contained 84% of asiaticoside was tested by the 
radioenzymatic assay against phospholipase A2 (PLA2), 
which play a role in neuroinflammation41, and in this 
experiment also proved anti-inflammatory property of CA 
through decreasing inducible Nitric Oxide Synthase (data not 
shown). Not only mitochondrial protection could protect the 
cells from oxidative stress, but increasing endogenous 
antioxidant play important role in the dopaminergic protection 
showed by decreasing dopaminergic neuron apoptosis (Fig. 7). 
Beside the role of mitochondrial protection, CA also 
protect the cells through the increasing of neurotrophin such as 
BDNF (Fig. 6) so that apoptosis could suppressed. The leaf 
extract of C. asiatica growing in China was shown to display 
neuroprotection through enhancing phosphorylation of cyclic 
AMP response element binding protein (CREB) in 
neuroblastoma cells in Aβ (1–42) proteins42. In this research 
based on the path analysis BDNF have bigger contribution to 
protect the dopaminergic neuron, rather than α-synuclein 
aggregation and dopamine conservation.  
 
V. CONCLUSION 
Our data suggest the methanolic extract of CA protect the 
dopaminergic neuron from rotenone toxicity through the 
increasing neurotrophic factor BDNF. Apoptosis or neuronal 
loss could decreased by BDNF protection and conservation of 
dopamine neurotransmitter in zebrafish-induced rotenone 
which administration of methanolic CA extract 10 µg/mL. 
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